A new study in the journal Nature examines what happens when pancreatic cancer cells are deprived of glucose, their normal fuel. Do the cells stop growing? No, they adapt by switching "fuels" to a different, ubiquitous biomolecule: uridine. The authors suggest that this discovery could lead to new treatments for this deadly cancer.
Kelsey Grammer is poised, quick witted, has a good sense of humor, and carries an aura of intellectual authority. He should be the next Jeopardy! host.
In the most common type of pancreatic cancer, the abnormal cells contain highly fragmented mitochondria. New research suggests that they can serve as a novel target in the treatment of pancreatic cancer.
Even under the best of circumstances, the five-year survival rate for pancreatic adenocarcinoma is devastating. According to the American Cancer Society, for stage IA it's just 14%. And for stage III – a horrifying 3%.
After being bitten by a mosquito, who among us hasn’t been tormented by the resulting itch? Now, imagine that intensity and urge to scratch spread over your entire body, in a constant and unrelenting fashion – night and day. This condition has a name: chronic generalized pruritus.
The Centers for Disease Control and Prevention is on a recent publishing push. It involves cancer prevention efforts, promotion of current statistics and encouragement of comprehensive plan implementations -- on all governmental, personal and public fronts.
In approximately one-third of patients diagnosed with pancreatic cancer with locally invasive tumors but without metastases, surgical removal of the tumor conferred significant survival benefit if done in conjunction with pre-operative chemotherapy and radiation.
A pancreatic cancer diagnosis most frequently indicates poor prognosis it has among the worst 5-year survival rate of all cancers which